Skip to main content
Fig. 10 | Cancer Cell International

Fig. 10

From: Pan-cancer analysis identifies CLEC12A as a potential biomarker and therapeutic target for lung adenocarcinoma

Fig. 10

Single-Cell Analysis of CLEC12A in LUAD. (A) UMAP plot visualizes the distribution of cell types in scRNA data (GSE146100). (B) The UMAP plot shows the cell-type expression of CLEC12A in the GSE146100 database. (C) The Kruskal-Wallis rank sum test assessed the difference in expression of CLEC12A in different immune cell types. (D) The bubble map shows the pathway differences in each cell type in the positive and negative CLEC12A expression cohorts. Red represents an increase in the score of the pathway (activation) in the cohort with positive expression of CLEC12A, and blue represents a decrease in the score of the pathway (inhibition) in the cohort with positive expression of CLEC12A. The size of the bubble indicates significance, and larger means more significance

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us